Peace deals may be elusive, and Gulf states fear the war is far from over https://t.co/8Z030R9aIJ ...

The ADP report, Steve, gave a good amount of pause for yesterday's session. Yet, the market still rallied to all-time highs. At what point right now is the business community going to say, "Hey, this is okay for us to get back to work and start hiring again. What needs to happen either in the economy or out of Washington DC policy makers. " Yeah. Well, good morning, Dom. You know, I the ADP report doesn't seem to correlate with uh all the official reports as you said, but you do have a confluence of events ...

This Node Monke sold for 1.29 $BTC (~USD $150,000) and nobody cares.Ordinals might truly be dead this time.in b4: "OMG the eth-fluencers are farming us for engagement again 😭". https://t.co/tNUXOvb7Eh ...

Digital twins is quite a big hot topic at the moment. Is there an idea of making a kind of digital twin of yourself for healthcare purposes. Yeah, we see that a lot and it can mean different things for different people.For the pharma industry, for example, where there's a lot of work trying to see how far we can go with clinical trials, if we manage to assemble uh virtual cohorts that are allowing us to in the end gain as much knowledge about the safety and efficacy of a drug, but without needing as many pe ...

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (CRSP 6.43%) and Viking Therapeutics (VKTX 4.01%), two mid-cap biotech companies that have lagged broader equities over the trailing-12-month period.Even with these poor performances, however, there are solid reasons to consider investing in these stocks, especially at current levels. Read on to find out more. 1. CRIS ...

MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to inform shareholders that it has received new results from a leading global fumed silica manufacturer (“LGFSM”) regarding the evaluation of materials produced during Phase 1 Test #5. Milestones: First Production of Material under Semi-Continuous Feedstock Feeding Protocol Techno ...

EDMONTON, Alberta, July 03, 2025 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Company" or "Regenx") (CSE: RGX) (OTCQB: RGXTF) is providing an update on the status of the restart of operations at its new facility in Newport, Tennessee as well as the application for funding from the US Department of Energy. Permit ApplicationRegenx is pleased to announce that all the necessary permits were granted on July 2, 2025. These permits authorize the Company to complete the construction of operations at the new facili ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. https://t.co/PHYF8D5Ubd https://t.co/PHYF8D5Ubd ...

Global Healthcare Biopharma catalysts to watch in 3Q25 With macroeconomic volatility and healthcare policy uncertainty persisting likely into the back half of the year, we continue to advocate for and highlight idiosyncratic catalysts with attractive risk/reward setups to drive alpha generation. Herein, we highlight and preview key catalysts in 3Q25 across the GS biotechnology coverage universe from pivotal studies: BMY's Cobenfy ADEPT-2 in Alzheimer's disease psychosis; LLY's orforglipron ATTAIN-1 in obesi ...

2 July 2025 | 4:55PM SGT Base Metals Tracker: Robust Chinese Demand And US Over-Importing Is Tightening The Ex-US Copper Market China's refined copper demand has increased by 12% YTD May. While export strength and a weak 2024 base contribute, domestic demand is a significant driver. China solar installations are up 150%, and AC sales are up 8%. Our end-use tracker indicates 13% YTD growth, after finished product exports, supporting 12% YTD growth in refined copper demand. We maintain our forecast of 6% grow ...